Improving effects of epigallocatechin-3-gallate on hemorheological abnormalities of aging guinea pigs

被引:12
作者
Cheng, Huey-Chuan
Chan, Chi-Ming
Tsay, Hsin-Sheng
Liang, Hong-Jen
Liang, Yu-Chih
Liu, Der-Zen
机构
[1] Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei, Taiwan
[2] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan
[3] Mackay Mem Hosp & Mackay Med, Dept Ophthalmol, Nursing & Management Coll, Taipei, Taiwan
[4] Cardinal Tien Hosp, Dept Ophthalmol, Taipei, Taiwan
[5] Chaoyang Univ Technol, Inst Biotechnol, Taichung, Taiwan
[6] Yuanpei Univ, Dept Food Sci, Hsinchu, Taiwan
关键词
aging; blood viscosity; epigallocatechin-3-gallate; erythrocyte deformability; malondialdehyde;
D O I
10.1253/circj.71.597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Epigallocatechin-3-gallate (EGCG) is the most potent antioxidant of all the green tea catechins. The objective of the present study was to find out whether it improved the age-induced hemorheological abnormalities or not. Methods and Results Twenty-four-month-old aging guinea pigs were used to test the effects of EGCG on hemorheolohgical properties. Orally feeding EGCG at 30 mg . kg(-1) . day(-1) for 28 days resulted in a decrease in erythrocyte membrane malondialdehyde, and further improved erythrocyte deformability and blood viscosity at high and middle shear rates. In addition, it also significantly reduced erythrocyte aggregation, and improved blood viscosity at low shear rates and viscoelasticity at oscillatory flow. Consequently, efficiency of blood oxygen transport in aged guinea pigs increased after administration with EGCG. Conclusions Orally feeding EGCG 30mg . kg(-1) . day(-1) for 28 days significantly improves the abnormal hemorheological parameters. These results suggest that EGCG has considerable potential as a substantial component for the development of new drugs or functional foods in improving the age-induced hemorheological abnormalities.
引用
收藏
页码:597 / 603
页数:7
相关论文
共 41 条
[1]   ERYTHROCYTE DEFORMABILITY IN AGING [J].
ABE, H ;
ORITA, M ;
ARICHI, S .
MECHANISMS OF AGEING AND DEVELOPMENT, 1984, 27 (03) :383-390
[2]   Hemorheological changes during human aging [J].
Ajmani, RS ;
Rifkind, JM .
GERONTOLOGY, 1998, 44 (02) :111-120
[3]   Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function [J].
Ajmani, RS ;
Metter, EJ ;
Jaykumar, R ;
Ingram, DK ;
Spangler, EL ;
Abugo, OO ;
Rifkind, JM .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :257-269
[4]   Erythrocyte deformability in high-tension and normal tension glaucoma [J].
Ates, H ;
Uretmen, O ;
Temiz, A ;
Andac, K .
INTERNATIONAL OPHTHALMOLOGY, 1998, 22 (01) :7-12
[5]   Association of hemorheological parameters and risk of stroke in hypertensives of Indian origin [J].
Banerjee, R ;
Nageswari, K ;
Puniyani, RR .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2000, 22 (7-8) :687-694
[6]   Blood viscosity and aging [J].
Coppola, L ;
Caserta, F ;
De Lucia, D ;
Guastafierro, S ;
Grassia, A ;
Coppola, A ;
Marfella, R ;
Varricchio, M .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2000, 31 (01) :35-42
[7]  
DINTENFASS L, 1975, BIORHEOLOGY, V12, P253
[8]  
Dong ZG, 1997, CANCER RES, V57, P4414
[9]  
Egorov V V, 1999, Vestn Oftalmol, V115, P5
[10]   An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage [J].
Grasso, G .
BRAIN RESEARCH REVIEWS, 2004, 44 (01) :49-63